Therefore, a good understanding of the mTOR pathway’s connectivity, its downstream effectors are of great importance toward our ability for genetic and pharmacological interventions for the amelioration of metabolic diseases, such as diabetes, obesity, and NAFLD. Here, MTOR is linked to metabolic dysfunction-associated steatotic liver disease.